Implantable Biosensor and Methods of Use Thereof

• US 20060241365A1
• Filed: 06/29/2006
• Published: 10/26/2006
• Est. Priority Date: 12/18/2003
• Status: Active Grant

• Current Assignee: Metronom Health Inc.
• Original Assignee: Metronom Health Inc.
• Inventors: Botvinick, Elliot, Bremer, Troy M.
• Granted Patent: US 8,543,182 B2
• Time in Patent Office: Days
• US Class Current: 600/345
• CPC Class Codes: A61B 5/14532 for measuring glucose, e.g. by tissue impedance measurement
• CPC Class Codes: A61B 5/1455 using optical sensors, e.g. spectral photometrical oximeters
• CPC Class Codes: A61B 5/1459 invasive, e.g. introduced into the body by a catheter A61B5/1464 takes precedence
• CPC Class Codes: A61B 5/1473 invasive, e.g. introduced into the body by a catheter A61B5/1482 takes precedence
• CPC Class Codes: A61B 5/14865 invasive, e.g. introduced into the body by a catheter or needle or using implanted sensors
• CPC Class Codes: A61B 5/1495 Calibrating or testing of in-vivo probes

Abstract

Provided herein is a stabilized oxygen transport matrix that includes a reversible oxygen binding protein, such as hemoglobin, immobilized throughout the stabilized oxygen transport matrix. The stabilized oxygen transport matrix is used to transport oxygen and can be used as an oxygen transport region and a reaction region of an analyte sensor, such as an implantable glucose sensor. The reversible binding protein can also function as an oxygen probe within the analyte sensor.

Claims

1. A sensor, comprising

a) an oxygen transport region comprising a first reversible oxygen binding protein, an oxygen permeable first surface in communication with an external environment, and an oxygen permeable second surface which is impermeable to target analyte;

b) a target analyte reaction region in communication with the oxygen transport region at the oxygen permeable second surface, wherein the target analyte reaction region comprises a target analyte oxidase enzyme, and a target analyte-permeable surface; and

c) a sensing region comprising at least one detector probe in communication with the target analyte reaction region.

2. The sensor of claim 1, wherein the target analyte and oxygen impermeable surface are located in the sensor such that the sensing region is in between the target analyte and oxygen impermeable surface and the oxygen transport region.

3. The sensor of claim 1, wherein the target analyte is selected from the group consisting of glucose, galactose, lactose, peroxide, cholesterol, amino acids, alcohol, lactic acid and mixtures thereof.

4. The sensor of claim 3, wherein the target analyte is glucose and the sensor is a glucose sensor.

5. The glucose sensor of claim 4, wherein the glucose sensor is an implantable glucose sensor.

6. The glucose sensor of claim 5, wherein the glucose sensor is a transcutaneous glucose sensor.

7. The sensor of claim 1, wherein the first reversible oxygen binding protein is an engineered hemeprotein or a heme derivative.

8. The sensor of claim 7, wherein the first reversible oxygen binding protein is hemoglobin.

9. The sensor of claim 1, wherein at least one of the oxygen transport region, the target analyte reaction region, and the sensing region comprise a stabilized matrix.

10. The sensor of claim 1, wherein the at least one detector probe is at least one substantially non-oxygen consuming detector probe.

11. The sensor of claim 10, wherein the sensing region further comprises an oxygen probe.

12. The sensor of claim 11, wherein the oxygen probe is a second reversible oxygen binding protein.

13. The sensor of claim 1, wherein the detector probe further comprises a spectrometer.

14. The sensor of claim 12, wherein the second reversible oxygen binding protein is an engineered hemeprotein or a heme derivative.

15. The sensor of claim 14, wherein the second reversible oxygen binding protein is hemoglobin.

16. The sensor of claim 1, wherein the first reversible oxygen binding protein is identical to the second reversible oxygen binding protein.

17. The sensor of claim 1, wherein the at least one detector probe is capable of emitting and/or receiving light.

18. The sensor of claim 17, wherein the at least one detector probe is capable of emitting and receiving light at an oxygen sensitive engineered hemeprotein, or heme derivative absorption wavelength.

19. The sensor of claim 18, wherein the at least one detector probe includes one or more emitters that emit light toward one or more receivers, wherein the emitters and the receivers both enter the sensor through a first end.

20. The sensor of claim 19, wherein the one or more emitters are comprised of one or more fiber optic fibers that are formed into a loop such that light exiting from the emitter fiber optic fibers travels in a path that is substantially opposite to light from a light source that enters the emitter fiber optic fibers.

21. The sensor of claim 19, wherein the one or more receivers are comprised of one or more fiber optic fibers that are formed into a loop such that light exiting from the emitter fiber optic fibers travels in a path that is substantially opposite to light from a light source that enters the emitter fiber optic fibers.

22. The sensor of claim 17, wherein the analyte reaction region comprises an analyte inlet substantially orthogonal to the surface at which the oxygen transport region contacts the analyte reaction region.

23. The sensor of claim 22, wherein the series of probes comprises a reference probe for measuring the reference oxygen concentration in the analyte reaction region, wherein the reference oxygen concentration is a measure of oxygen concentration in the reaction region in the absence of the analyte.

24. The sensor of claim 23, wherein the reference probe communicates with the analyte reaction region beyond or at the point at which the effects of the analyte on an oxygen profile within the reaction region are not detectable.

25. A method for measuring a concentration of an analyte, comprising

transporting oxygen from an external environment through an oxygen transport region within a sensor to an analyte reaction region of the sensor using a first reversible oxygen binding protein;

reacting a portion of the transported oxygen with the analyte enzymatically in the analyte reaction region to form a product; and

measuring oxygen or a product of the reaction of oxygen and the analyte in a sensing region comprising the analyte reaction region or a sensing region in contact with the analyte reaction region, thereby measuring the concentration of the analyte.

26. The method of claim 25, wherein the analyte being measured is glucose, galactose, lactose, peroxide, cholesterol, amino acids, alcohol, or lactic acid.

27. The method of claim 26, wherein the analyte being measured is glucose.

28. The method of claim 25, wherein the measuring is performed at least at a first time point and a second time point, thereby providing information regarding changes in analyte concentration.

29. The method of claim 25, wherein oxygen is transported from the external environment comprising subcutaneous tissue to the analyte reaction region.

30. The method of claim 25, wherein oxygen is transported from the external environment to the analyte reaction region using an engineered hemeprotein or a heme derivative as the first reversible oxygen binding protein.

31. The method of claim 30, wherein oxygen is transported from the external environment to the analyte reaction region using hemoglobin as the first reversible oxygen binding protein.

32. The method of claim 25, wherein oxygen is measured by measuring oxygen binding of an oxygen probe.

33. The method of claim 32, wherein oxygen binding is measured using a spectrometer measuring at least one wavelength.

34. The method of claim 33, wherein the spectrometer measures absorption of the oxygen binding protein.

35. The method of claim 32, wherein oxygen binding of a second reversible binding protein oxygen probe is measured.

36. The method of claim 33, wherein the second reversible oxygen binding protein is an engineered hemeprotein or a heme derivative.

37. The method of claim 36, wherein the second reversible oxygen binding protein is hemoglobin.

38. The method of claim 25, wherein the measuring is performed using one or more detector probes.

39. The method of claim 38, wherein the measuring is performed using a population of substantially non-oxygen consuming detector probes.

40. The method of claim 32, wherein light is emitted and received by the detector probe at an oxygen sensitive engineered hemeprotein or heme derivative wavelength.

41. The method of claim 32, wherein light is emitted by one or more emitters towards one or more receivers.

42. The method of claim 41, wherein light travels through one or more emitter fiber optic fibers from a light source emitting in a first direction and then travels in a second direction that is substantially opposite the first direction through at least a portion of the sensing region where it is received by one or more receiver fiber optic fibers.

43. The method of claim 42, wherein light travels through a loop in the emitter fiber optic fibers before it enters at least a portion of the sensing region.

44. The method of claim 38, wherein the analyte enters the reaction region through an analyte inlet.

45. The method of claim 44, wherein the analyte concentration is determined by using the signal from at least one oxygen probe that is sufficiently close to the analyte inlet to be sensitive to analyte-derived oxygen gradients within the sensing region along with the signal from at least a second oxygen probe that is sufficiently far from the analyte inlet to act as a reference probe for the oxygen profile.

46. The method of claim 45, wherein a reference probe is sufficiently far from the analyte inlet so that the signal from the reference probe is not substantially affected by the analyte entering the analyte inlet.

47. The method of claim 44, wherein the oxygen transport region provides a sufficient oxygen flux to the reaction region such that the enzyme reaction is not oxygen limited.

48. The method of claim 47, wherein the size of the analyte inlet, the concentration of an enzyme in the reaction region, and the concentration of the reversible oxygen binding protein in the reaction region are tuned to provide an analyte sensitive oxygen gradient near the inlet such that the desired dynamic range of analyte concentrations can be measured, and to provide a analyte insensitive oxygen reference concentration distal to the inlet.

49. A stabilized oxygen transport matrix, comprising a reversible oxygen binding protein immobilized throughout the stabilized oxygen transport matrix.

50. The stabilized oxygen transport matrix of claim 49, wherein the reversible oxygen binding protein is an engineered hemeprotein, or a heme derivative.

51. The stabilized oxygen transport matrix of claim 50, wherein the reversible oxygen binding protein is hemoglobin.

52. A method for transporting oxygen from a first area having a relatively higher oxygen concentration to a second area having a relatively lower oxygen concentration, comprising contacting oxygen from the first area with a first surface of a stabilized oxygen transport matrix that includes a reversible oxygen binding protein immobilized throughout the stabilized oxygen transport matrix, and transporting oxygen away from the first surface of the stabilized oxygen transport matrix to a second surface of the oxygen transport matrix, wherein the second surface of the oxygen transport matrix contacts the second area.

53. The method of claim 52, wherein the rate of oxygen transport through the matrix is substantially higher than observed by simple diffusion.

54. The method of claim 52, wherein oxygen transport within the stabilized oxygen transport matrix is mediated by the binding and releasing of oxygen by the reversible oxygen binding protein comprising a hemeprotein, or an engineered heme derivative.

55. The method of claim D1, wherein the transporting is carried out by an oxygen binding protein immobilized in the matrix at a concentration sufficient to measurably increase the flux of oxygen across the second surface of the oxygen transport matrix as compared to that achieved by simple diffusion.